| |
| Friday, July 30, 2010 |
|
Henan health officials visit UK as part of joint HIV/AIDS collaboration
|
|
MOH holds symposium on increasing hospital workplace security and safety
|
|
Liaoning releasing revised provincial reimbursement drug list
|
|
Jinan cautiously adds private facilities to rural health system
|
| |
 |
| |
| Thursday, July 29, 2010 |
|
On-line central drug procurement set for 30day roll-out in Heilongjiang
|
|
Kangmei Pharmaceutical plans Sichuan TCM investments of RMB 600 million
|
|
Leo Pharmaceutical recalls IV antibiotic product in China
|
|
HCV is China’s main focus on World Hepatitis Day
|
|
Major foreign CT/MRI OEMs see large China potential, despite obstacles
|
|
Qinghai health department in gear to help earthquake reconstruction
|
| |
|
| |
| Wednesday, July 28, 2010 |
|
Novartis signs artimether API purchase agreement with Kunming Pharma
|
|
Doctors make mouse calls: Beijing hospital launches pilots access system
|
|
SFDA continues to target illegal drug/device advertising
|
|
Close fitting genes- Affymetrix to launch China specific SNP microarray
|
|
MSD-Sinopharm marketing partnership seems likely
|
| |
|
| |
| Tuesday, July 27, 2010 |
|
RDPAC raises strong objection to NRDC drug pricing draft measures
|
|
Beijing municipal health bureau releases rosy reform rollout report
|
|
Pain, pain, go away- high tech anesthesia center set up in Guangdong
|
|
Nanjing Tongrentang plans RMB 600 infrastructure investment
|
|
Major counterfeit drug ring busted, bogus abatacept among products
|
| |
|
| |
| Monday, July 26, 2010 |
|
MOH announcement re-emphasizes rural health improvements and coverage
|
|
Renminbi-ology: Biotech Billionaire list published
|
|
New retail pharmacy to focus on premium branded drugs
|
|
SFDA calls attention to lamivudine and telbivudine ADRs
|
| |
|
| |
| Friday, July 23, 2010 |
|
Insect-borne disease project takes wing in Yunnan
|
| |
